Fasting increases tobramycin oral absorption in mice

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 4, 2010, Pages 1644-1646

  De Leo, Luigina ^a   Di Toro, Nicola ^a   Decorti, Giuliana ^a   Malusà, Noelia ^b   Ventura, Alessandro ^a   Not, Tarcisio ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Sanitary Services Agency Number 1   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TOBRAMYCIN;

ARTICLE; DIET RESTRICTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; GASTROINTESTINAL ABSORPTION; INTESTINE MUCOSA PERMEABILITY; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL AVAILABILITY; FASTING; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; LACTULOSE; MALE; MICE; MICE, INBRED BALB C; RHAMNOSE; TOBRAMYCIN;

EID: 77950108013     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01172-09     Document Type: Article

References (27)

1. Anderson, J. M., and C. M. Van Itallie. 1995. Tight junctions and the molecular basis for regulation of paracellular permeability. Am. J. Physiol. 269:G467-G475.
2. Arrieta, M. C., L. Bistritz, and J. B. Meddings. 2006. Alterations in intestinal permeability. Gut 55:1512-1520.
3. Aungst, B. J. 2000. Intestinal permeation enhancers. J. Pharm. Sci. 89:429-442.
4. Banerjee, D., and D. Stableforth. 2000. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Drugs 60:1053-1064.
5. Boza, J. J., D. Moennoz, J. Vuichoud, A. R. Jarret, D. Gaudard-de-Weck, R. Fritsche, A. Donnet, E. J. Schiffrin, G. Perruisseau, and O. Ballevre. 1999. Food deprivation and refeeding influence growth, nutrient retention and functional recovery of rats. J. Nutr. 129:1340-1346.
6. Cao, X., S. T. Gibbs, L. Fang, H. A. Miller, C. P. Landowski, H. C. Shin, H. Lennernas, Y. Zhong, G. L. Amidon, L. X. Yu, and D. Sun. 2006. Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model. Pharm. Res. 23:1675-1686.
7. Chambers, H. F. 2006. Amynoglicosides, p. 1155-1171. In L. L. Brunton, J. S. Lazo, and K. L. Parker (ed.), Goodman & Gilman's: the pharmacological basis of therapeutics, 11th ed. McGraw-Hill, New York, NY.
8. Chiou, W. L., and A. Barve. 1998. Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm. Res. 15:1792-1795.
9. Chiou, W. L., C. Ma, S. M. Chung, T. C. Wu, and H. Y. Jeong. 2000. Similarity in the linear and non-linear oral absorption of drugs between human and rat. Int. J. Clin. Pharmacol. Ther. 38:532-539.
10. Duro, D., D. Kamin, and C. Duggan. 2008. Overview of pediatric short bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 47:S33-S36.
11. Fasano, A., and S. Uzzau. 1997. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J. Clin. Invest. 99:1158-1164.
12. Gemer, O., E. Zaltztein, and R. Gorodischer. 1983. Absorption of orally administered gentamicin in infants with diarrhea. Pediatr. Pharmacol. 3:119-123.
13. Hombach, J., H. Hoyer, and A. Bernkop-Schnurch. 2008. Thiolated chitosans: development and in vitro evaluation of an oral tobramycin sulphate delivery system. Eur. J. Pharm. Sci. 33:1-8.
14. Katouzian, F., D. Sblattero, T. Not, A. Tommasini, E. Giusto, D. Meiacco, M. Stebel, R. Marzari, A. Fasano, and A. Ventura. 2005. Dual sugar gut-permeability testing on blood drop in animal models. Clin. Chim. Acta 352:191-197.
15. Madara, J. L. 1989. Loosening tight junctions. Lessons from the intestine. J. Clin. Invest. 83:1089-1094.
16. Meddings, J. B., and I. Gibbons. 1998. Discrimination of site-specific alterations in gastrointestinal permeability in the rat. Gastroenterology 114:83-92.
17. Meddings, J. B., J. Jarand, S. J. Urbanski, J. Hardin, and D. G. Gall. 1999. Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat. Am. J. Physiol. 276:G951-G957.
18. Michael, S., M. Thole, R. Dillmann, A. Fahr, J. Drewe, and G. Fricker. 2000. Improvement of intestinal peptide absorption by a synthetic bile acid derivative, cholylsarcosine. Eur. J. Pharm. Sci. 10:133-140.
19. Miranda, J. C., M. S. Schimmel, G. M. Mimms, W. Spinelli, J. M. Driscoll, L. S. James, and T. S. Rosen. 1984. Gentamicin absorption during prophylactic use for necrotizing enterocolitis. Dev. Pharmacol. Ther. 7:303-306.
20. Rodriguez, P., N. Darmon, P. Chappuis, C. Candalh, M. A. Blaton, C. Bouchaud, and M. Heyman. 1996. Intestinal paracellular permeability during malnutrition in guinea pigs: effect of high dietary zinc. Gut 39:416-422.
21. Rohrbaugh, T. M., R. Anolik, C. S. August, F. T. Serota, and P. A. Koch. 1984. Absorption of oral aminoglycosides following bone marrow transplantation. Cancer 53:1502-1506.
22. Sakaguchi, E. 2003. Digestive strategies of small hindgut fermentors. Anim. Sci. J. 74:327-337.
23. Sung, J. H., S. S. Hong, S. H. Ahn, H. Li, S. Y. Seo, C. H. Park, B. S. Park, and S. J. Chung. 2006. Mechanism for increased bioavailability of tacrine in fasted rats. J. Pharm. Pharmacol. 58:643-649.
24. Thanou, M., J. C. Verhoef, P. Marbach, and H. E. Junginger. 2000. Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo. J. Pharm. Sci. 89:951-957.
25. Welsh, F. K., S. M. Farmery, K. MacLennan, M. B. Sheridan, G. R. Barclay, P. J. Guillou, and J. V. Reynolds. 1998. Gut barrier function in malnourished patients. Gut 42:396-401.
26. Worthington, B. S., and E. S. Boatman. 1974. The influence of protein malnutrition on ileal permeability to macromolecules in the rat. Am. J. Dig. Dis. 19:43-55.
27. Zhao, Y. H., M. H. Abraham, J. Le, A. Hersey, C. N. Luscombe, G. Beck, B. Sherborne, and I. Cooper. 2003. Evaluation of rat intestinal absorption data and correlation with human intestinal absorption. Eur. J. Med. Chem. 38: 233-243.